个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
周三盘中有12只医疗保健类股走势
Gainers
- Avadel Pharmaceuticals (NASDAQ:AVDL) shares rose 42.9% to $8.43 during Wednesday's regular session. As of 13:30 EST, Avadel Pharmaceuticals's stock is trading at a volume of 1.6 million, which is 229.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $510.7 million.
- First Wave BioPharma (NASDAQ:FWBI) stock moved upwards by 22.42% to $2.02. As of 13:30 EST, this security is trading at a volume of 1.2 million shares, making up 151.0% of its average full-day volume over the last 100 days. The company's market cap stands at $2.8 million.
- Cingulate (NASDAQ:CING) shares moved upwards by 22.36% to $1.45. As of 13:30 EST, this security is trading at a volume of 187.6K shares, making up 202.4% of its average full-day volume over the last 100 days. The company's market cap stands at $16.3 million.
- SAB Biotherapeutics (NASDAQ:SABS) stock increased by 18.83% to $0.92. Trading volume for SAB Biotherapeutics's stock is 269.6K as of 13:30 EST. This is 432.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $39.3 million.
- NantHealth (NASDAQ:NH) stock increased by 16.58% to $0.28. The company's market cap stands at $32.3 million.
- Nuwellis (NASDAQ:NUWE) shares rose 14.34% to $0.52. Trading volume for this security as of 13:30 EST is 715.1K, which is 21.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.4 million.
Losers
- Avenue Therapeutics (NASDAQ:ATXI) shares fell 43.4% to $8.21 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of 2.1 million shares, making up 102.1% of its average full-day volume over the last 100 days. The company's market cap stands at $12.1 million.
- Nutex Health (NASDAQ:NUTX) stock fell 13.8% to $1.25. As of 13:30 EST, this security is trading at a volume of 640.4K shares, making up 56.0% of its average full-day volume over the last 100 days. The company's market cap stands at $812.2 million.
- Pharming (NASDAQ:PHAR) shares fell 12.53% to $10.2. The company's market cap stands at $665.4 million.
- Athersys (NASDAQ:ATHX) shares decreased by 12.17% to $1.66. As of 13:30 EST, Athersys's stock is trading at a volume of 949.7K, which is 61.3% of its average full-day volume over the last 100 days. The company's market cap stands at $506.4 million.
- Sotera Health (NASDAQ:SHC) stock decreased by 10.33% to $7.21. The current volume of 1.3 million shares is 73.9% of Sotera Health's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $2.0 billion.
- IO Biotech (NASDAQ:IOBT) stock fell 10.3% to $2.7. The market value of their outstanding shares is at $77.8 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Gainers
赢家
- Avadel Pharmaceuticals (NASDAQ:AVDL) shares rose 42.9% to $8.43 during Wednesday's regular session. As of 13:30 EST, Avadel Pharmaceuticals's stock is trading at a volume of 1.6 million, which is 229.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $510.7 million.
- First Wave BioPharma (NASDAQ:FWBI) stock moved upwards by 22.42% to $2.02. As of 13:30 EST, this security is trading at a volume of 1.2 million shares, making up 151.0% of its average full-day volume over the last 100 days. The company's market cap stands at $2.8 million.
- Cingulate (NASDAQ:CING) shares moved upwards by 22.36% to $1.45. As of 13:30 EST, this security is trading at a volume of 187.6K shares, making up 202.4% of its average full-day volume over the last 100 days. The company's market cap stands at $16.3 million.
- SAB Biotherapeutics (NASDAQ:SABS) stock increased by 18.83% to $0.92. Trading volume for SAB Biotherapeutics's stock is 269.6K as of 13:30 EST. This is 432.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $39.3 million.
- NantHealth (NASDAQ:NH) stock increased by 16.58% to $0.28. The company's market cap stands at $32.3 million.
- Nuwellis (NASDAQ:NUWE) shares rose 14.34% to $0.52. Trading volume for this security as of 13:30 EST is 715.1K, which is 21.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.4 million.
- Avadel制药公司纳斯达克股票代码:AVDL在周三的例行交易中上涨42.9%,至8.43美元。截至美国东部时间13:30,Avadel PharmPharmticals的股票成交量为160万股,是过去100日平均全天成交量的229.9%。他们流通股的市值为5.107亿美元。
- 第一波生物制药纳斯达克股票代码:FWBI上涨22.42%,至2.02美元。截至美国东部时间13:30,该证券成交量为120万股,占其过去100日全天平均成交量的151.0。该公司的市值为280万美元。
- 扣带状纳斯达克(Sequoia Capital:Cing)股价上涨22.36%,至1.45美元。截至美国东部时间13:30,该证券成交量为187.6K股,占其过去100日全天平均成交量的202.4。该公司的市值为1,630万美元。
- SAB生物治疗学(纳斯达克:SABS)股价上涨18.83%,至0.92美元。截至美国东部时间13:30,SAB BioTreateutics的股票成交量为269.6K。这是过去100日平均全天成交量的432.2%。他们流通股的市值为3930万美元。
- NantHealth(纳斯达克:NH)股票上涨16.58%,至0.28美元。该公司的市值为3,230万美元。
- 纽韦利斯纳斯达克(Tmall:NUWE)股价上涨14.34%,至0.52美元。截至美国东部时间13:30,该证券的成交量为715.1K,是过去100天全天平均成交量的21.2%。他们流通股的市值为540万美元。
Losers
失败者
- Avenue Therapeutics (NASDAQ:ATXI) shares fell 43.4% to $8.21 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of 2.1 million shares, making up 102.1% of its average full-day volume over the last 100 days. The company's market cap stands at $12.1 million.
- Nutex Health (NASDAQ:NUTX) stock fell 13.8% to $1.25. As of 13:30 EST, this security is trading at a volume of 640.4K shares, making up 56.0% of its average full-day volume over the last 100 days. The company's market cap stands at $812.2 million.
- Pharming (NASDAQ:PHAR) shares fell 12.53% to $10.2. The company's market cap stands at $665.4 million.
- Athersys (NASDAQ:ATHX) shares decreased by 12.17% to $1.66. As of 13:30 EST, Athersys's stock is trading at a volume of 949.7K, which is 61.3% of its average full-day volume over the last 100 days. The company's market cap stands at $506.4 million.
- Sotera Health (NASDAQ:SHC) stock decreased by 10.33% to $7.21. The current volume of 1.3 million shares is 73.9% of Sotera Health's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $2.0 billion.
- IO Biotech (NASDAQ:IOBT) stock fell 10.3% to $2.7. The market value of their outstanding shares is at $77.8 million. See Also:
- 大道治疗公司纳斯达克(Tmall:ATXI)周三盘中股价下跌43.4%,至8.21美元。截至美国东部时间13:30,该证券成交量为210万股,占其过去100日全天平均成交量的102.1。该公司的市值为1,210万美元。
- Nutex健康纳斯达克(Tmall:NUTX)股价下跌13.8%,至1.25美元。截至美国东部时间13:30,该证券成交量为640.4K股,占其过去100天全天平均成交量的56.0%。该公司的市值为8.122亿美元。
- 加密化纳斯达克股价下跌12.53%,至10.2美元。该公司的市值为6.654亿美元。
- Athersys纳斯达克(Tmall:ATHX)股价下跌12.17%,至1.66美元。截至美国东部时间13:30,Athersys的股票成交量为949.7K,是其过去100天全天平均成交量的61.3%。该公司的市值为5.064亿美元。
- Sotera Health纳斯达克(Sequoia Capital:SHC)股价下跌10.33%,至7.21美元。目前130万股的成交量是Sotera Health过去100天全天平均成交量的73.9%(最近一次更新是在美国东部时间13:30)。该公司的市值为20亿美元。
- IO Biotech纳斯达克(Tmall:IOBT)股价下跌10.3%,至2.7美元。他们流通股的市值为7780万美元。另见:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!